Quanterix (QTRX)
(Delayed Data from NSDQ)
$15.59 USD
-0.45 (-2.81%)
Updated Apr 25, 2024 04:00 PM ET
After-Market: $15.59 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
D Value A Growth C Momentum C VGM
Price, Consensus and EPS Surprise
QTRX 15.59 -0.45(-2.81%)
Will QTRX be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for QTRX based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for QTRX
Quanterix (QTRX) AD Offering Gets FDA's Breakthrough Device Tag
Quanterix Corporation (QTRX) Reports Q4 Loss, Tops Revenue Estimates
QTRX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Quanterix (QTRX) Expands in Alzheimer's Testing With Alliances
Here's Why Quanterix Corporation (QTRX) is a Great Momentum Stock to Buy
Does Quanterix Corporation (QTRX) Have the Potential to Rally 33.74% as Wall Street Analysts Expect?
Other News for QTRX
Commit To Purchase Quanterix At $12.50, Earn 13% Annualized Using Options
Analysts’ Top Healthcare Picks: Quanterix (QTRX), Intuitive Surgical (ISRG)
Quanterix Leadership Changes and Executive Severance Enhancements
Analysts Offer Insights on Healthcare Companies: Syndax Pharmaceuticals (SNDX) and Quanterix (QTRX)
Quanterix’s Strong IP Position Fuels Buy Rating in Alzheimer’s Diagnostic Market